1. Home
  2. IIF vs PROF Comparison

IIF vs PROF Comparison

Compare IIF & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIF

Morgan Stanley India Investment Fund Inc.

HOLD

Current Price

$23.78

Market Cap

231.5M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.91

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIF
PROF
Founded
1993
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
231.5M
230.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IIF
PROF
Price
$23.78
$7.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
45.4K
288.0K
Earning Date
01-01-0001
03-05-2026
Dividend Yield
13.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,297,000.00
Revenue This Year
N/A
$64.23
Revenue Next Year
N/A
$113.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.94
52 Week Low
$18.95
$3.76
52 Week High
$24.41
$8.95

Technical Indicators

Market Signals
Indicator
IIF
PROF
Relative Strength Index (RSI) 17.07 52.49
Support Level $24.26 $7.45
Resistance Level $24.77 $8.60
Average True Range (ATR) 0.24 0.59
MACD -0.05 -0.04
Stochastic Oscillator 3.72 41.60

Price Performance

Historical Comparison
IIF
PROF

About IIF Morgan Stanley India Investment Fund Inc.

Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: